Bouchareb, Rihab

P2Y2 receptor represses IL-6 expression by valve interstitial cells through Akt: implication for calcific aortic valve disease

El Husseini, D., Boulanger, M.-C., Mahmut, A., Bouchareb, R., Laflamme, M.-H., Fournier, D., Pibarot, P., Bossé, Y., & Mathieu, P. (2014) · Journal of Molecular and Cellular Cardiology

Cardiac Valve Diseases and TreatmentsAdenosine and Purinergic Signaling

Cited by 150

Innate and Adaptive Immunity in Calcific Aortic Valve Disease

Mathieu, P., Bouchareb, R., & Boulanger, M.-C. (2015) · Journal of Immunology Research

Cardiac Valve Diseases and TreatmentsAtherosclerosis and Cardiovascular Diseases

Cited by 121

Proteomic architecture of valvular extracellular matrix

Bouchareb, R., Guauque-Olarte, S., Snider, J., Zaminski, D., Anyanwu, A., Stelzer, P., & Lebeche, D. (2021) · JACC: Basic to Translational Science

Cardiac Valve Diseases and TreatmentsAdvanced Proteomics Techniques and Applications

Cited by 52

Adenosine derived from ecto-nucleotidases in calcific aortic valve disease promotes mineralization through A2a adenosine receptor

Mahmut, A., Boulanger, M.-C., Bouchareb, R., Hadji, F., & Mathieu, P. (2015) · Cardiovascular Research

Adenosine and Purinergic SignalingCardiac Valve Diseases and Treatments

Cited by 48

Carbonic anhydrase XII in valve interstitial cells promotes the regression of calcific aortic valve stenosis

Bouchareb, R., Côté, N., Marie-Chloé-Boulanger, Le Quang, K., El Husseini, D., Asselin, J., Hadji, F., Lachance, D., Shayhidin, E. E., Mahmut, A., et al. (2015) · Journal of Molecular and Cellular Cardiology

Cardiac Valve Diseases and TreatmentsEnzyme function and inhibition

Cited by 25